| Eurlex法規(guī)編號: |
(EU) 2023/1757 |
| OJ編號: |
OJ L 224, 12.9.2023, p. 28–33 |
| 中文標(biāo)題: |
2023年9月11日委員會實(shí)施條例(EU) 2023/1757:修訂實(shí)施條例(EU) No 540/2011,關(guān)于延長以下活性物質(zhì)的授權(quán):芐磺隆、氯甲枯、氯麥隆、氯馬宗、達(dá)米諾齊特、溴氰菊酯、丁香酚、氟二惡腈、氟非那西特、氟美他林、磷噻嗪、香葉醇、MCPA、MCPB、喔草酯、芐草丹、喹唑洛福對-乙基、喹唑洛佛對-四呋喃基、5-硝基水楊酸鈉、鄰硝基苯酚鈉、對硝基酚鈉、磺酰氟、吡喃毒丁、百里酚和三甲苯磺?。▋?nèi)容與EEA相關(guān)) |
| 原文標(biāo)題: |
Commission Implementing Regulation (EU) 2023/1757 of 11 September 2023 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances bensulfuron, chlormequat, chlorotoluron, clomazone, daminozide, deltamethrin, eugenol, fludioxonil, flufenacet, flumetralin, fosthiazate, geraniol, MCPA, MCPB, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sodium 5-nitroguaiacolate, sodium o-nitrophenolate, sodium p-nitrophenolate, sulfuryl fluoride, tebufenpyrad, thymol, and tritosulfuron (Text with EEA relevance) |
| 發(fā)布日期 |
2023-09-12 |
| 原文鏈接 |
查看歐盟官網(wǎng)文件 |
閱讀:194次